Well Told Grants

Federal grant recipients / Maryland

Federal grants to Kalocyte Inc

Baltimore, Maryland · Small businesses · UEI MJMKM31FM667

Kalocyte Inc in Baltimore, Maryland received $6.0 million in federal grants from fiscal 2021 to 2025, across 3 awards. Its largest program was Cardiovascular Diseases Research, with $3.5 million. In fiscal 2025 it was awarded $995,470.

From USAspending.gov award records, updated November 7, 2026.

By year

Federal grants to Kalocyte Inc by fiscal year
Fiscal yearAwardsAmount
FY 20211$499,999
FY 20220$0
FY 20231$1.1 million
FY 20242$3.5 million
FY 20251$995,470

An award funded in several years counts in each of them, so yearly awards add up to more than the five-year total.

Programs that fund Kalocyte Inc

Every program, fiscal 2021 to 2025
ProgramAwardsAmount
Cardiovascular Diseases Research 93.8372$3.5 million
Military Medical Research and Development 12.4201$2.5 million

Awarding agencies

AgencyAwardsAmount
Department of Health and Human Services2$3.5 million
Department of Defense1$2.5 million

Largest awards

The 3 largest awards by money obligated in fiscal 2021 to 2025
AwardProgramFirst actionAmount
Erythromer: nanoscale biosynthetic red cell substitute - research summary/abstract erythromer (EM) is a novel biosynthetic blood substitute developed to address the critically unmet need for emergency transfusion in situations where the use of banked red blood cells (RBCS) are either not available o
ASST_NON_R44HL135965_075 on USAspending
Cardiovascular Diseases ResearchMay 19, 2023$3.0 million
Optimized lyophilization and reconstitution of erythromer, a bio-inspired, artificial red blood cell
ASST_NON_HT94252410157_097 on USAspending
Military Medical Research and DevelopmentApril 8, 2024$2.5 million
Manufacturing scale-up, purification, and analytical method development, validation and qualification for KC1003, key precursor for erythromer (rbc substitute) - project summary/abstract erythromer (EM) is a novel biosynthetic blood substitute developed to address the critically unmet need for emerg
ASST_NON_SB1HL135965_075 on USAspending
Cardiovascular Diseases ResearchJuly 28, 2021$499,999

Amounts are net obligations: money committed, minus any amounts taken back. They are not payments. See how our data works.

Questions people ask

How much federal grant money does Kalocyte Inc get?

$6.0 million in 3 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.

Which agency gives Kalocyte Inc the most?

The Department of Health and Human Services, with $3.5 million in 2 awards. The Department of Defense follow.

What is Kalocyte Inc's largest federal grant?

$3.0 million under Cardiovascular Diseases Research, with its first action in the period on May 19, 2023. That counts only the money obligated in fiscal 2021 to 2025.

Which federal programs fund Kalocyte Inc?

Its largest are Cardiovascular Diseases Research and Military Medical Research and Development.

Other grant recipients in Baltimore

Largest federal grant recipients in Maryland · Federal grants in Maryland